Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
41
COCSF Quote, Financials, Valuation and Earnings
Last price:
$9.3900
Seasonality move
:
1.8%
Day range:
$8.8450 - $8.8450
52-week range:
$7.0000 - $10.3000
Dividend yield:
0%
P/E ratio:
14.88x
P/S ratio:
1.25x
P/B ratio:
2.50x
Volume:
--
Avg. volume:
1.3K
1-year change:
-0.17%
Market cap:
$18.6B
Revenue:
$15.4B
EPS (TTM):
$0.59
Earnings Data
Next earnings date for COCSF
--
Most recent earnings per share
$0.12
Beat by $0.12
(Apr 25/2025)
Consensus Estimate
--
(Apr 25/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
COCSF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $4B | -- | -- | -- | -- |
| 06/30/2025 | Q2 | $4B | -- | -- | -- | -- |
| 04/25/2025 | Q1 | $3.5B | $3.4B | $0.12 | -- | -- |
| 02/21/2025 | Q4 | $3.5B | $3.8B | $0.17 | -- | -- |
| 10/25/2024 | Q3 | $3.5B | $3.7B | $0.15 | -- | -- |
| 07/19/2024 | Q2 | $3.8B | $4B | $0.15 | -- | -- |
| 04/24/2024 | Q1 | $3.6B | $3.8B | $0.14 | -- | -- |
| 02/22/2024 | Q4 | $3.9B | $3.6B | $0.15 | -- | -- |
| 10/25/2023 | Q3 | $3.5B | $3.7B | $0.15 | -- | -- |
| 07/25/2023 | Q2 | $3.6B | $3.5B | $0.13 | -- | -- |
| 04/27/2023 | Q1 | $3B | $3.1B | $0.10 | -- | -- |
| 02/23/2023 | Q4 | -- | $3.1B | $0.17 | -- | -- |
| 10/24/2022 | Q3 | -- | $2.8B | $0.10 | -- | -- |
| 07/25/2022 | Q2 | -- | $2.9B | $0.11 | -- | -- |
| 04/28/2022 | Q1 | -- | $2.5B | $0.07 | -- | -- |
| 02/24/2022 | Q4 | -- | $2.6B | $0.13 | -- | -- |
| 10/27/2021 | Q3 | -- | $2.4B | $0.08 | -- | -- |
| 07/26/2021 | Q2 | -- | $2.4B | $0.08 | -- | -- |
| 04/26/2021 | Q1 | -- | $2.2B | $0.07 | -- | -- |
| 02/25/2021 | Q4 | -- | $2.4B | $0.07 | -- | -- |
| 10/26/2020 | Q3 | -- | $2.1B | $0.05 | -- | -- |
| 07/22/2020 | Q2 | -- | $1.9B | $0.04 | -- | -- |
| 04/29/2020 | Q1 | -- | $2.3B | $0.06 | -- | -- |
| 02/26/2020 | Q4 | -- | $2.7B | $0.05 | -- | -- |
| 10/25/2019 | Q3 | -- | $2.5B | $0.10 | -- | -- |
| 07/25/2019 | Q2 | -- | $2.5B | $0.09 | -- | -- |
| 04/26/2019 | Q1 | -- | $2.4B | $0.06 | -- | -- |
| 02/26/2019 | Q4 | -- | $2.6B | $0.13 | -- | -- |
| 10/25/2018 | Q3 | -- | $2.3B | $0.08 | -- | -- |
| 07/26/2018 | Q2 | -- | $2.3B | $0.07 | -- | -- |
| 04/25/2018 | Q1 | -- | $2.4B | $0.06 | -- | -- |
| 02/22/2018 | Q4 | -- | $2.4B | -$0.61 | -- | -- |
| 10/25/2017 | Q3 | -- | $2.5B | $0.08 | -- | -- |
| 07/24/2017 | Q2 | -- | $2.7B | $0.06 | -- | -- |
| 04/26/2017 | Q1 | -- | $2.5B | $0.14 | -- | -- |
| 02/24/2017 | Q4 | -- | $2.9B | $0.09 | -- | -- |
| 10/25/2016 | Q3 | -- | $2.3B | $0.06 | -- | -- |
| 07/27/2016 | Q2 | -- | $2.2B | $0.05 | -- | -- |
| 03/31/2016 | Q1 | -- | $2.1B | $0.06 | -- | -- |
| 12/31/2015 | Q4 | -- | $2.6B | $0.09 | -- | -- |
| 09/30/2015 | Q3 | -- | $2.3B | $0.06 | -- | -- |
Coca-Cola Femsa SAB de CV Earnings Questions
-
How Much did Coca-Cola Femsa SAB de CV Generate in Revenue Last Quarter?
Coca-Cola Femsa SAB de CV reported $3.4B worth of top line sales in its most recent quarter.
-
Did Coca-Cola Femsa SAB de CV Beat Earnings Last Quarter?
Coca-Cola Femsa SAB de CV announced earnings per share of $0.12 which represents a beat of analyst forecast a -- per share.
-
Is Coca-Cola Femsa SAB de CV Profitable?
Coca-Cola Femsa SAB de CV reported $1.6B that represents $0.74 per share over the last quarter.
-
What is the Analyst Consensus for Coca-Cola Femsa SAB de CV EPS Next Year?
Coca-Cola Femsa SAB de CV's earnings are forecast to grow from $0.62 per share to -- per share next year representing an increase of --.
-
When is Coca-Cola Femsa SAB de CV's Earnings Date?
Currently, Coca-Cola Femsa SAB de CV has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on October 16, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
